Genworth Financial (NYSE: GNW) insider transactions
In the twelve months to 10 November 2026, executives and directors of Genworth Financial reported 7 open-market sales of 384,708 shares ($3.7m) and 0 open-market purchases, by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 3 September 2026 | McInerney Thomas J | President and CEO; Director | Open-market sale | −100,000 | $10.53 | 5,068,883 | Form 4 |
| 24 August 2026 | Hagerman Melissa | EVP and Chief HR Officer | Open-market sale | −14,708 | $9.92 | 192,539 | Form 4 |
| 24 August 2026 | Hagerman Melissa | EVP and Chief HR Officer | Gift | −11,000 | — | 181,539 | Form 4 |
| 21 August 2026 | Karawan Gregory S. | EVP and General Counsel | Open-market sale | −40,000 | $9.91 | 343,121 | Form 4 |
| 13 July 2026 | Shah Samir B. | Pres. & CEO, CareScout | Option exercise | +15,965 | — | 131,919 | Form 4 |
| 13 July 2026 | Shah Samir B. | Pres. & CEO, CareScout | Shares withheld for tax | −8,160 | $9.47 | 123,759 | Form 4 |
| 27 May 2026 | McInerney Thomas J | President and CEO; Director | Gift | −200,000 | — | 5,168,883 | Form 4 |
| 22 May 2026 | McInerney Thomas J | President and CEO; Director | Open-market sale | −100,000 | $9.27 | 5,368,883 | Form 4 |
| 22 May 2026 | Restrepo Robert P JR | Director | Open-market sale | −50,000 | $9.12 | 92,655 | Form 4 |
| 21 May 2026 | Taylor Morris C. | EVP & CIO | Option exercise | +21,521 | — | 21,521 | Form 4 |
| 21 May 2026 | Taylor Morris C. | EVP & CIO | Shares withheld for tax | −6,478 | $9.19 | 15,043 | Form 4 |
| 20 May 2026 | Higgins Melina E | Director | Grant or award | +31,547 | $9.03 | 163,729 | Form 4 |
| 20 May 2026 | Restrepo Robert P JR | Director | Grant or award | +18,264 | $9.03 | 142,655 | Form 4 |
| 20 May 2026 | Goodman Jill R | Director | Grant or award | +18,264 | $9.03 | 92,655 | Form 4 |
| 20 May 2026 | Sarsynski Elaine A | Director | Grant or award | +32,100 | $9.03 | 164,999 | Form 4 |
| 20 May 2026 | Van Wyk Steven C. | Director | Grant or award | +32,100 | $9.03 | 77,676 | Form 4 |
| 20 May 2026 | Conrad G Kent | Director | Grant or award | +18,264 | $9.03 | 92,655 | Form 4 |
| 20 May 2026 | Dyson Karen Elizabeth | Director | Grant or award | +18,264 | $9.03 | 92,655 | Form 4 |
| 20 May 2026 | Mills Howard D. III | Director | Grant or award | +18,264 | $9.03 | 92,655 | Form 4 |
| 20 May 2026 | Smith Ramsey D. | Director | Grant or award | +18,264 | $9.03 | 92,655 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Genworth Financial page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.